HIV prophylaxis within a treatment protocol for sexual assault victims: Rationale for the decision

Nonoccupational postexposure prophylaxis following sexual assault in industrialized low-HIV-prevalence countries: A review

“…Ten studies found high-risk exposures positively associated with offering nPEP. Three studies found financial hardship and lack of insurance associated with lower rates of prescription (Linden et al, 2005;Loutfy et al, 2008;Moe & Grau, 2001). The remaining four factors associated with offering nPEP were reported in one study apiece (see Table 8).…”

“…In US adults, three early studies found acceptance at less than 10% (Moe & Grau, 2001;Pesola, Westfal, & Kuffner, 1999;Straight & Heaton, 2007). Rates of nPEP acceptance for the remaining four US adult populations ranged from moderate (20-40%) in one state-wide, and one single-site study (Merchant et al, 2008;Myles, Hirozawa, Katz, Kimmerling, & Bamberger, 2000) to greater than 75% in two other single-site studies (Linden et al, 2005;Merchant et al, 2003).…”

“…Four studies reported the frequency of baseline HIV testing (Bechtel, Ryan, & Gallagher, 2008;Campbell et al, 2006;Merchant, Phillips, Delong, Mayer, & (2007) 172 - Garcia et al (2005) 347 278 (80%) Kerr et al (2003) 676 - Limb et al (2002) 150 10 (6%) Reeves et al (2004) 92 - Rey et al (2008) 98 -Sonder et al (2007) 29 - Templeton et al (2005) 146 117 (80%) Wiebe et al (2000) 258 -Studies with US populations conducted pre-CDC guidelines Linden et al (2005) 181 167 (92%) Merchant et al (2008) 780 610 (78%) Merchant et al (2003) 461 286 (62%) Moe and Grau (2001) 58 48 (82%) Myles et al (2000) 376 354 (94%) Pesola et al (1999) 27 - Straight and Heaton (2007) 179,149 -Note: *The percentage reflects the number of patients eligible out of the total sample size. Becker, 2008;Straight & Heaton, 2007).…”

“…No further information was available. Moe and Grau's (2001) protocol stipulated patients must present within 24-h postexposure to be eligible, excluding 10 of 58 patients. No reasons were given in the remaining 16 studies for not offering nPEP to patients.…”

Violência sexual como questão de saúde pública: atenção específica em serviços de saúde

“…Em estudo realizado com mães adolescentes, grávidas entre 10 e 14 anos de idade, SANTOS e SCHOR (2003) (BAMBERGER et al, 1999;FAÚNDES et al, 2002;BABL et al, 2000;MINISTÉRIO DA SAÚDE, 2002b Vários autores (DREZETT, 2002a;MOE & GRAU, 2001;BATEMAN, 2000;BAMBERGER et al, 1999;BABL et al 2000;WIEBE et al 2000) ressaltam A indicação da profilaxia medicamentosa depende da avaliação dos fatores de risco associados à exposição e do tempo decorrido entre a violência e o comparecimento ao CHS. O esquema medicamentoso adotado encontra-se relacionado no quadro, a seguir:…”